Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DescripTion of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/atoRvastatin/Perindopril sinGle Pill Combination trEatmenT in Patients With Arterial Hypertension and Dyslipidemia in the Daily Clinical Practice. (TARGET)

NCT05764317 is registered in ClinicalTrials.gov with Servier Russia as lead sponsor.

NCT NCT05764317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05764317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DescripTion of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/atoRvastatin/Perindopril sinGle Pill Combination trEatmenT in Patients With Arterial Hypertension and Dyslipidemia in the Daily Clinical Practice. (TARGET)
Lead sponsor
Servier Russia
Phase
Observational
Overall status
Completed
Start date
April 30, 2023
Completion date
February 20, 2024
Enrollment
409 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension, htn